Efficacy of Compound Unani Formulations in the Management of ‘Kathrat-i-Tamth’ (Menorrhagia): A Case Study

Abstract

This case report evaluates the efficacy of a compound Unani formulation in managing Kaṭhrat-i-Tamṭh (Menorrhagia) due to Endometrial hyperplasia in a 29-year-old obese, nulliparous woman. Presenting with a 5-year history of prolonged heavy bleeding (10-20 days/month), large clots, fatigue, and anaemia (Hb: 8g/dl), she had found no relief with previous Ayurvedic and allopathic treatments. Ultrasonography revealed increased endometrial thickness (20-21mm). The intervention comprised oral Unani medications; Qurs-e-Kehruba one tablet morning and evening, Qurse kustae faulad two tablets morning and evening, Safoof-e-Habis-ud-Dam 5gm morning and evening, powder of Haleela, Baleela and Amla 5gm morning and evening and  Majoon-e- Dabeed-ul-Ward 5gm morning and evening and a daily Shibb-e-Yamani, Poste anar, Mazu sabz based sitz bath powder of Imly paste on lower abdomen for one month. Significant improvement was observed within 15 days, with complete cessation of heavy bleeding. Follow-up showed normalized cycle duration, absence of clots, and enhance haemoglobin levels. This case demonstrates that a tailored Unani formulation can effectively manage menorrhagia secondary to endometrial hyperplasia by leveraging the astringent, haemostatic, anti-inflammatory, and anti-proliferative properties of its ingredients, offering a viable non-surgical and non-hormonal treatment option. This case report is justified as it provides valuable clinical evidence for the application of traditional Unani medicine in treating a complex gynaecological condition (menorrhagia due to endometrial hyperplasia) that did not respond to conventional treatments. It documents a successful, non-hormonal, and non-surgical interventional strategy, highlighting the potential of integrative medicine. Reporting such cases is essential for generating hypotheses for future larger-scale clinical trials and offers an alternative treatment paradigm for patients seeking complementary therapies.